EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bridging the gap: a genetically validated avian chorioallantoic membrane platform for investigation of spontaneous circulating tumor cells

Dennis Roth iD, Rui P L Neves iD, Julia Geheb, Christian Ballmeyer, Nathalie Gaßmann, Kiki C Andree, Monica Sudarsanam, Christiane Driemel, Celine Örencik, Andrè Franken, Eslam Elmaghraby, Sven H Loosen und 6 weitere

Molecular Oncology · 2026-11 · 20 (11) · 2611-2623

DOI: 10.1002/1878-0261.70336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 18.09.2026. Verfasst von Dennis Roth und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery (A), Heinrich-Heine-University and University Hospital Duesseldorf, Germany. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Chorioallantoic Membrane. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Forschungskommission Duesseldorf, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating tumor cells (CTCs) are clinically relevant markers of metastasis and prognosis in gastrointestinal (GI) cancers. However, their extreme rarity and the limitations of current in vivo models severely restrict mechanistic studies of tumor cell dissemination. Here, we demonstrate for the first time that the avian chorioallantoic membrane (CAM) assay can serve as a biologically relevant and ethically advantageous 3R‐compliant (Replacement, Reduction, and Refinement) in vivo model for investigating spontaneous CTC generation. Six green fluorescent protein (GFP)‐labeled human colorectal, pancreatic, and cholangiocarcinoma cell lines were xenografted onto the CAM. Using a standardized workflow, we achieved reliable detection and isolation of GFP‐positive single CTCs from small‐volume CAM blood samples. Critically, we reproducibly confirmed the presence of spontaneously shed CAM‐derived CTCs independent of GFP expression using three established, clinically relevant CTC detection platforms. Subsequent single‐cell whole‐genome amplification enabled downstream short‐tandem repeat (STR) profiling to authenticate CTC identity, alongside detection of tumor‐specific point mutations and copy number alterations (CNAs). Isolated CTCs exhibited high genetic concordance with their parental cell lines, validating the technical robustness of our workflow and establishing the CAM assay as a versatile, scalable platform for investigating hematogenous dissemination and CTC biology outside of mammalian models. Consequently, the CAM assay opens new avenues for early mechanistic and pharmacological CTC research, including functional studies of patient‐derived material.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingChorioallantoic MembraneAnimalsHumansCell Line, TumorGreen Fluorescent ProteinsChickens

Stichwörter der Autor:innen

3R methodschorioallantoic membrane (CAM)circulating tumor cells (CTCs)liquid biopsymetastasissingle‐cell genomics

Substanzen

Green Fluorescent Proteins

Autor:innen und Institutionen

  • Department of Surgery (A), Heinrich-Heine-University and University Hospital Duesseldorf, Germany.
  • Liquid Biopsy Center Duesseldorf, Center for Integrated Oncology Aachen, Bonn, Cologne, Germany.
  • VyCAP B.V, Enschede, The Netherlands.
  • Department of Obstetrics and Gynecology, University Hospital and Medical Faculty of the Heinrich-Heine-University Duesseldorf, Germany.
  • Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Duesseldorf, Medical Faculty of Heinrich Heine University Duesseldorf, Germany.
  • JCCU Translational Surgical Oncology (A430), German Cancer Research Center (DKFZ), Heidelberg, Germany.

ORCID-Profile: Dennis Roth, Rui P L Neves, Nikolas H Stoecklein, Georg Fluegen

Förderung

  • Forschungskommission Duesseldorf
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Roth, D., Neves, R. P. L., Geheb, J., Ballmeyer, C., Gaßmann, N., Andree, K. C., Sudarsanam, M., Driemel, C., Örencik, C., Franken, A., Elmaghraby, E., Loosen, S. H., Christoph, R., Schoelch, S., Neubauer, H., Knoefel, W. T., Stoecklein, N. H., & Fluegen, G. (2026). Bridging the gap: a genetically validated avian chorioallantoic membrane platform for investigation of spontaneous circulating tumor cells. Molecular Oncology, 20(11), 2611-2623. https://doi.org/10.1002/1878-0261.70336

Vancouver

Roth D, Neves RPL, Geheb J, Ballmeyer C, Gaßmann N, Andree KC, et al. Bridging the gap: a genetically validated avian chorioallantoic membrane platform for investigation of spontaneous circulating tumor cells. Molecular Oncology. 2026;20(11):2611-2623. doi:10.1002/1878-0261.70336

BibTeX
@article{Roth2026,
  author = {Roth, Dennis and Neves, Rui P L and Geheb, Julia and Ballmeyer, Christian and Gaßmann, Nathalie and Andree, Kiki C and Sudarsanam, Monica and Driemel, Christiane and Örencik, Celine and Franken, Andrè and Elmaghraby, Eslam and Loosen, Sven H and Christoph, Roderburg and Schoelch, Sebastian and Neubauer, Hans and Knoefel, Wolfram T and Stoecklein, Nikolas H and Fluegen, Georg},
  title = {Bridging the gap: a genetically validated avian chorioallantoic membrane platform for investigation of spontaneous circulating tumor cells},
  journal = {Molecular Oncology},
  year = {2026},
  volume = {20},
  number = {11},
  pages = {2611--2623},
  doi = {10.1002/1878-0261.70336}
}
Kostenlos starten →